Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0000914062-13-000154
Filing Date
2013-04-09
Accepted
2013-04-09 17:18:30
Documents
1
Period of Report
2012-12-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 5  
1 PRIMARY DOCUMENT edgar.xml 5 3106
  Complete submission text file 0000914062-13-000154.txt   4532
Mailing Address 7 WELLS AVENUE STE 34 NEWTON MA 02459
Business Address 7 WELLS AVENUE STE 34 NEWTON MA 02459 617-559-0033
GALECTIN THERAPEUTICS INC (Issuer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7 WHEELWRIGHT ROAD MEDFIELD MA 02052
Business Address
Prelack Steven (Reporting) CIK: 0001302315 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-31791 | Film No.: 13751727